;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Calithera Biosciences amends IPO

    Calithera Biosciences Inc., South San Francisco, Calif. Business: Cancer Date announced: 2014-09-19 Type: IPO To be raised: Up to $90 million Shares: 6 million Price: $13-$15 Underwriters: Citigroup; Leerink Partners; …

    Published on 9/22/2014
  • Civitas amends IPO

    Civitas Therapeutics Inc., Chelsea, Mass. Business: Drug delivery, Neurology, Pulmonary Date announced: 2014-09-15 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: JPMorgan; …

    Published on 9/22/2014
  • Dermira amends IPO

    Dermira Inc., Redwood City, Calif. Business: Dermatology Date announced: 2014-09-19 Type: IPO To be raised: Up to $85.6 million Shares: 5.4 million Price: $14-$16 Underwriters: Citigroup; Leerink Partners; Guggenheim …

    Published on 9/22/2014
  • EyeGate amends IPO

    EyeGate Pharmaceuticals Inc., Waltham, Mass. Business: Ophthalmic Date announced: 2014-09-12 Type: IPO To be raised: Up to $26.9 million Shares: 1.9 million Price: $12-$14 Underwriter: Aegis Capital Overallotment: 288,…

    Published on 9/22/2014
  • AbGenomics completes venture financing

    AbGenomics International Inc., Los Altos, Calif. Business: Antibodies Date completed: 2014-08-27 Type: Venture financing Raised: $13.2 million Note: The company raised $13.2 million, according to an SEC filing.

    Published on 9/22/2014
  • Airway Therapeutics completes venture financing

    Airway Therapeutics LLC, Cincinnati, Ohio Business: Pulmonary Date completed: 2014-09-10 Type: Venture financing Raised: $4.6 million Investors: CincyTech; Cincinnati Children's Hospital Medical Center; Queen City …

    Published on 9/22/2014
  • Aratana completes follow-on

    Aratana Therapeutics Inc. (NASDAQ:PETX), Kansas City, Kan. Business: Veterinary Date completed: 2014-09-17 Type: Follow-on Raised: $47.9 million Shares: 5.2 million Price: $9.25 Shares after offering: 34.6 million …

    Published on 9/22/2014
  • Avraham Pharmaceuticals completes venture financing

    Avraham Pharmaceuticals Ltd., Yavneh, Israel Business: Neurology Date completed: 2014-09-17 Type: Venture financing Raised: $4.5 million Investors: Yissum Ltd.; Pontifax; Clal Biotechnology Industries; Technion Research…

    Published on 9/22/2014
  • Cardiorentis completes venture financing

    Cardiorentis AG, Zug, Switzerland Business: Cardiovascular Date completed: 2014-09-17 Type: Venture financing Raised: EUR45 million ($58.2 million) Investor: Healthcare Royalty Partners

    Published on 9/22/2014
  • Foamix completes IPO

    Foamix Ltd. (NASDAQ:FOMX), Ness Ziona, Israel Business: Drug delivery Date completed: 2014-09-18 Type: IPO Raised: $40.2 million Shares: 6.7 million Price: $6 Shares after offering: 21.5 million Underwriters: Barclays …

    Published on 9/22/2014
  • Genisphere completes venture financing

    Genisphere LLC, Hatfield, Pa. Business: Supply/Service Date completed: 2014-09-16 Type: Venture financing Raised: $2 million Investors: Corporate Fuel Partners; existing investors

    Published on 9/22/2014
  • Medifocus completes private placement of units

    Medifocus Inc. (TSX-V:MFS; OTCQX:MDFZF), Vancouver, B.C. Business: Cancer Date completed: 2014-09-15 Type: Private placement of units Raised: $1.6 million Units: 10.3 million Price: $0.16 (unit) Shares after offering: …

    Published on 9/22/2014
  • MGB Biopharma completes venture financing

    MGB Biopharma Ltd., Glasgow, U.K. Business: Infectious Date completed: 2014-09-17 Type: Venture financing Raised: L2.7 million ($4.4 million) Investors: Archangel Informal Investment; Barwell plc; Tri Capital Ltd.; …

    Published on 9/22/2014
  • Nordic Nanovector completes venture financing

    Nordic Nanovector A/S, Oslo, Norway Business: Cancer Date completed: 2014-09-16 Type: Venture financing Raised: NOK50 million ($7.8 million) Investor: Existing investors Note: The company raised NOK50 million ($7.8 …

    Published on 9/22/2014
  • Oncothyreon completes follow-on

    Oncothyreon Inc. (NASDAQ:ONTY), Seattle, Wash. Business: Cancer Date completed: 2014-09-18 Type: Follow-on Raised: $20 million Shares: 10 million Price: $2 Shares after offering: 80.8 million Underwriters: Cowen; H.C. …

    Published on 9/22/2014
  • Oncothyreon completes private placement of convertible preferred stock

    Oncothyreon Inc. (NASDAQ:ONTY), Seattle, Wash. Business: Cancer Date completed: 2014-09-18 Type: Private placement of convertible preferred stock Raised: $20 million Shares: 10,000 Price: $2,000 Shares outstanding prior…

    Published on 9/22/2014
  • PhosImmune completes venture financing

    PhosImmune Inc., Charlottesville, Va. Business: Cancer Date completed: 2014-09-12 Type: Venture financing Raised: $125,000 Investor: Center for Innovative Technology (CIT) GAP Fund Note: The company raised $125,000 in …

    Published on 9/22/2014
  • Poxel completes venture financing

    Poxel S.A., Lyon, France Business: Endocrine/Metabolic Date completed: 2014-09-09 Type: Venture financing Raised: EUR5 million ($6.5 million) Investor: Kreos Capital Note: The company declined to disclose terms of the …

    Published on 9/22/2014
  • ProQR Therapeutics completes IPO

    ProQR Therapeutics N.V. (NASDAQ:PRQR), Leiden, the Netherlands Business: Pulmonary Date completed: 2014-09-18 Type: IPO Raised: $97.5 million Shares: 7.5 million Price: $13 Shares after offering: 22.2 million …

    Published on 9/22/2014
  • Pulmologix completes venture financing

    Pulmologix AB, Stockholm, Sweden Business: Inflammation Date completed: 2014-09-16 Type: Venture financing Raised: EUR9.6 million ($12.4 million) Investors: Novo Seeds; Sunstone Capital; Forbion Capital Partners; …

    Published on 9/22/2014
  • Qu Biologics completes venture financing

    Qu Biologics Inc., Vancouver, B.C. Business: Autoimmune, Cancer Date completed: 2014-09-17 Type: Venture financing Raised: C$5.1 million ($4.7 million) Investor: Not disclosed

    Published on 9/22/2014
  • Ribomic completes IPO

    Ribomic Inc., Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date completed: 2014-09-16 Type: IPO Raised: Y2.8 billion ($25.7 million) Shares: 1.2 million Price: Y2,300 Shares after offering: 12.1 million …

    Published on 9/22/2014
  • Scholar Rock completes venture financing

    Scholar Rock LLC, Cambridge, Mass. Business: Autoimmune, Musculoskeletal, Cancer Date completed: 2014-09-15 Type: Venture financing Raised: $20 million Investors: Arch Venture Partners; Polaris Partners; EcoR1 Capital; …

    Published on 9/22/2014
  • Synereca completes venture financing

    Synereca Pharmaceuticals Inc., Oklahoma City, Okla. Business: Infectious Date completed: 2014-09-16 Type: Venture financing Raised: $1.4 million Investors: Accele Venture Partners I L.P.; i2E Inc. Note: The financing is…

    Published on 9/22/2014
  • Tokai completes IPO

    Tokai Pharmaceuticals Inc. (NASDAQ:TKAI), Cambridge, Mass. Business: Cancer Date completed: 2014-09-17 Type: IPO Raised: $97.2 million Shares: 6.5 million Price: $15 Shares after offering: 21.8 million Underwriters: BMO…

    Published on 9/22/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993